Search research articles
Contact Us
Filters
Showing results (111-120 of 133) with videos related to
Page
of 14
Sort By:
Cancer Immunology, Immunotherapy : CII
|
July 7, 2026
CXCL13-CXCR5 signaling in CD8<sup>+</sup> T cell recruitment and lymphoid immune organization in clear cell renal cell carcinoma
Daniel D Shapiro, Kye D Nichols, Moon Hee Lee, et al.
Cancers
|
November 10, 2020
Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)
Soohyeon Lee, Seock-Ah Im, Gun Min Kim, et al.
Cancer Research and Treatment
|
February 6, 2018
S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
Choong-Kun Lee, Minkyu Jung, Hyo Song Kim, et al.
Annals of Hematology
|
August 26, 2009
Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide
Youngil Koh, Soo-Mee Bang, Jae Hoon Lee, et al.
The Korean Journal of Internal Medicine
|
November 22, 2005
High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization
Jin Seok Ahn, Seonyang Park, Seock-Ah Im, et al.
Oncoimmunology
|
February 17, 2025
Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses
Rita Turpin, Karita Peltonen, Jenna H Rannikko, et al.
Japanese Journal of Clinical Oncology
|
February 12, 2008
Report of AIDS-related lymphoma in South Korea
Jin-Soo Kim, Seok Jin Kim, Jin-Seok Kim, et al.
Thrombosis and Haemostasis
|
March 12, 2009
Vascular events in Korean patients with myeloproliferative neoplasms and their relationship to JAK2 mutation
Soo-Mee Bang, Jong-Seok Lee, Jeong Yeal Ahn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 2, 2015
A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09
Ki Hyeong Lee, Ji-Yeon Kim, Moon Hee Lee, et al.
Annals of Hematology
|
March 30, 2010
Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety
Sung Sook Lee, Cheolwon Suh, Bong-Seog Kim, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 133) with videos related to
Sort By:
Page
of 14
Cancer Immunology, Immunotherapy : CII
|
July 7, 2026
CXCL13-CXCR5 signaling in CD8<sup>+</sup> T cell recruitment and lymphoid immune organization in clear cell renal cell carcinoma
Daniel D Shapiro, Kye D Nichols, Moon Hee Lee, et al.
Cancers
|
November 10, 2020
Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)
Soohyeon Lee, Seock-Ah Im, Gun Min Kim, et al.
Cancer Research and Treatment
|
February 6, 2018
S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
Choong-Kun Lee, Minkyu Jung, Hyo Song Kim, et al.
Annals of Hematology
|
August 26, 2009
Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide
Youngil Koh, Soo-Mee Bang, Jae Hoon Lee, et al.
The Korean Journal of Internal Medicine
|
November 22, 2005
High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization
Jin Seok Ahn, Seonyang Park, Seock-Ah Im, et al.
Oncoimmunology
|
February 17, 2025
Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses
Rita Turpin, Karita Peltonen, Jenna H Rannikko, et al.
Japanese Journal of Clinical Oncology
|
February 12, 2008
Report of AIDS-related lymphoma in South Korea
Jin-Soo Kim, Seok Jin Kim, Jin-Seok Kim, et al.
Thrombosis and Haemostasis
|
March 12, 2009
Vascular events in Korean patients with myeloproliferative neoplasms and their relationship to JAK2 mutation
Soo-Mee Bang, Jong-Seok Lee, Jeong Yeal Ahn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
October 2, 2015
A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09
Ki Hyeong Lee, Ji-Yeon Kim, Moon Hee Lee, et al.
Annals of Hematology
|
March 30, 2010
Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety
Sung Sook Lee, Cheolwon Suh, Bong-Seog Kim, et al.
Page
of 14